rhBMP‐2 injected in a calcium phosphate paste (α‐BSM) accelerates healing in the rabbit ulnar osteotomy model
Open Access
- 1 November 2003
- journal article
- Published by Wiley in Journal of Orthopaedic Research
- Vol. 21 (6) , 997-1004
- https://doi.org/10.1016/s0736-0266(03)00082-2
Abstract
This study evaluated the ability of recombinant human bone morphogenetic protein‐2 (rhBMP‐2) delivered in an injectable calcium phosphate carrier (α‐BSM) to accelerate healing in a rabbit ulna osteotomy model compared to untreated surgical controls. Healing was assessed by radiography, histology and biomechanics. Bilateral mid‐ulnar osteotomies were created in 16 skeletally mature rabbits. One limb in each animal was injected with either 0.1 mg rhBMP‐2/α‐BSM (BMP) (N = 8) or buffer/α‐BSM (BSM) (N = 8). Contralateral osteotomies served as untreated surgical controls (SXCT). Gamma scintigraphy showed 75%, 45% and 5% of the initial 125I‐rhBMP‐2 dose was retained at the osteotomy site at 3 h, 1 week and 3 weeks. The biological activity of rhBMP‐2 (alkaline phosphatase activity from bioassay) extracted from α‐BSM incubated in vitro up to 30 days at 37°C was unchanged. Radiographs demonstrated complete bridging of the BMP limbs at 4 weeks whereas none of the BSM or SXCT limbs were bridged. Post‐mortem peripheral quantitative computed tomography determined mineralized callus area was 62% greater in BMP limbs compared to SXCT limbs. Torsional stiffness and strength were 63% and 103% greater in BMP limbs compared to SXCT limbs. There was no difference in torsional properties between BSM and SXCT limbs. Failure occurred outside the osteotomy in four out of seven of the BMP limbs. All BSM and SXCT limbs failed through the osteotomy. Histology showed bony bridging of the osteotomy and no residual carrier in the BMP limbs. BSM and SXCT groups showed less mature calluses composed of primarily fibrocartilaginous tissue and immature bone in the osteotomy gap. These data indicate rhBMP‐2 delivered in α‐BSM accelerated healing in a rabbit ulna osteotomy model compared to BSM and SXCT groups. © 2003 Orthopaedic Research Society. Published by Elsevier Science Ltd. All rights reserved.Keywords
This publication has 26 references indexed in Scilit:
- The Use of rhBMP-2 in Interbody Fusion CagesSpine, 2000
- Displaced tibial shaft fractures: A prospective randomized study of closed intramedullary nailing versus cast treatment in 53 patientsActa Orthopaedica, 2000
- ??-BSM??: A Biomimetic Bone Substitute and Drug Delivery VehicleClinical Orthopaedics and Related Research, 1999
- Effect of Recombinant Human Bone Morphogenetic Protein-2 on Fracture Healing in a Goat Tibial Fracture ModelJournal of Bone and Mineral Research, 1998
- Sustained release emphasizing recombinant human bone morphogenetic protein-2Advanced Drug Delivery Reviews, 1998
- Stimulatory effect of bone morphogenetic protein-2 on osteoclast-like cell formation and bone-resorbing activityJournal of Bone and Mineral Research, 1995
- Periodontal Repair in Dogs: Recombinant Human Bone Morphogenetic Protein‐2 Significantly Enhances Periodontal RegenerationThe Journal of Periodontology, 1995
- The bone morphogenetic protein family and osteogenesisMolecular Reproduction and Development, 1992
- Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cellsEndocrinology, 1992
- Novel Regulators of Bone Formation: Molecular Clones and ActivitiesScience, 1988